Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.
about
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Development of a highly sensit ...... le fractions in cell-free DNA.
@en
Development of a highly sensit ...... le fractions in cell-free DNA.
@nl
type
label
Development of a highly sensit ...... le fractions in cell-free DNA.
@en
Development of a highly sensit ...... le fractions in cell-free DNA.
@nl
prefLabel
Development of a highly sensit ...... le fractions in cell-free DNA.
@en
Development of a highly sensit ...... le fractions in cell-free DNA.
@nl
P2093
P2860
P50
P1433
P1476
Development of a highly sensit ...... ele fractions in cell-free DNA
@en
P2093
Alexandra S Whale
Alison Devonshire
Ana Fernandez-Gonzalez
Bradley Durham
Carole A Foy
Emma Green
Gerwyn M Jones
Greg Jones
Hadas Raveh-Amit
James Clark
P2860
P304
P356
10.1371/JOURNAL.PONE.0194630
P407
P577
2018-03-16T00:00:00Z